Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2026
The global proteomics market is projected to reach USD 55.9 billion by 2026, at a CAGR of 16.6% during the forecast period. An increase in the research activity, especially in the area of personalized medicine and drug discovery, is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the market growth. However, the drawbacks related to data management and storage, the high cost of instruments, and the disconnect between biomarker discovery and their subsequent approval are some of the major market challenges.
To know about the assumptions considered for the study, Request for Free Sample Report
Proteomics Market Global Dynamics
Drivers: Rising prevalence of cancer and associated genetic disorders
In the past decade, several significant discoveries were made in the field of life sciences, completion of the sequencing of the human genome being one of them. The next significant biomedicine milestone was the characterization of human protein, which is a relatively new and extremely dynamic branch of science focused on the evaluation of gene expression at the proteome level. With limited research performed in proteomics to date, current proteomics is limited to deal with several issues such as protein identification, quantification, characterization of post-translational modification, structure and function elucidation, and description of possible interactions. However, with increasing research efforts, both monetary and technical, the field of proteomics is expected to incorporate technologies that can be applied to serum and tissue samples in order to extract important biological information in the form of biomarkers to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as patients with cancer.
Opportunities: Increasing prominence of nanoproteomics
The field of nanotechnology has been associated with several proteomics applications such as phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and analytical detection of biomarker proteins using array techniques. This has led to the emergence of nanoproteomics, a science involving the application of proteomics techniques aided by nanotechnology. This technique is utilized as a complementary component to revolutionize proteomics through different kinds of nanotechnology applications, including nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.
Challenges: High cost of instruments
Companies rely on accessible structural data and trial-and-error methods to determine the compounds that either stimulate or disable target proteins. The structuring of proteins involves the use of rapid, high-throughput tools and machines. X-ray crystallography is one of the most widely used methods in proteomics, which conducts gene cloning, protein expression, and purification and crystallization of proteins. All these processes need a large number of laboratory hours, increasing the per sample testing costs. Such high prices of instruments and reagents make it difficult for developing countries to venture into the field of proteomics.
Immunoassay reagents segment accounted for the largest share of the proteomics market, by reagents, in 2020
The proteomics market, by reagent, is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. In 2020, the immunoassay reagents segment accounted for the largest share of the market. The large share of this segment can be attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages.
Pharmaceutical companies segment accounted for the largest share in the market, by end user, in 2020
Based on end users, the proteomics market is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and other end users. In 2020, the pharmaceutical companies segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing research funding for genomics and proteomics research and the increasing outsourcing of research activities to various pharmaceutical companies with in-house CRO services.
North America commanded the largest share of the proteomics market in 2020
The global proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. In 2020, North America accounted for the largest share in the market. This can be attributed to the increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.
To know about the assumptions considered for the study, download the pdf brochure
Proteomics Market Key Players
The major players operating in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).
Scope of the Proteomics Market Report
|
Report Metrics |
Details |
|
Market Size value 2026 |
USD 55.9 billion |
|
Growth Rate |
16.6% CAGR |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
Immunoassay Reagents & Pharmaceutical Companies |
|
Forecasts up to |
2026 |
|
Market Segmentation |
Instrumentation Technology, Reagent, Software & Service, Application, End User and Region |
|
Proteomics Market Growth Drivers |
|
|
Proteomics Market Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This report categorizes the proteomics market into the following segments and subsegments:
By Instrumentation Technology
- Spectroscopy
- Mass Spectroscopy
- NMR Spectroscopy
- CD Spectroscopy
- Chromatography
- HPLC
- Ion Chromatography
- Affinity Chromatography
- Supercritical Fluid Chromatography
- Electrophoresis
- Gel Electrophoresis
- Capillary Electrophoresis
- Protein Microarrays
- Biochips
- Lab-on-Chips
- Protein Chips
- Micrparray Instruments
- Integrated Systems
- Microarray Scanners
- Arrayers
- Biochips
- X Ray Crystallography
- Surface Plasmon Resonance
- Protein Fractionation
By Reagent
- Immunoassay Reagents
- Spectroscopy Reagents
- Chromatography Reagents
- Protein Microarray Reagents
- X Ray Crystallography Reagents
- Electrophoresis Reagents
- Protein Fractionation Reagents
By Software & Service
- Core Proteomics Services
- Protein Identification Services
- Protein Characterization Services
- Quantitative Proteomic Services
- Protein Purification Services
- Protein Sequencing Services
- Custom Assay Services
- Bioinformatics Software & Services
- Bioinformatics Software
- Bioinformatics Tools
- Bioinformatics Databases
By Application
- Clinical Diagnostics
- Cancer
- Infectious Diseases
- Diabetes
- Neurological Disorders
- Immune Diseases
- Cardiovascular Diseases
- Other Clinical Diagnostic Applications
- Drug Discovery
- Target Discovery
- Lead Identification
- Lead Optimization
- Preclinical Studies
- Other Application
By End User
- Hospitals
- Clinical Laboratories
- Pharmaceutical Companies
- Academic Research Laboratories
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Switzerland
- Rest of Europe
- Asia Pacific
- Japan
- China
- Australia
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2021, Thermo Fisher Scinetific (US) acquired Phitonex (US).
- In 2020, Perkin Elmer (US) launched SARS-COV-2 Antigen Elisa Test.
- In 2020, Bruker Corporation (US) acquired Integrated Proteomics Applications IP2 software.
Frequently Asked Questions (FAQ):
What are the recent trends affecting the proteomics market?
Recent trends affecting the proteomics market are growing prevalence of cancer research and prevalence of cancer; increasing R&D expenditures by government and private bodioes; and increasing trend of outsourcing by pharmaceutical companies to CROs.
Who are the key players in this market?
The key players in this market are: Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).
What are the key types of proteomics products/ services?
The key products and services in the porteomics market are: Instruments and accessories; reagents & assays, proteomics services; and bioinformatics software and services.
Which region is lucrative for the proteomics market?
The emerging economies in Asia Pacific region like China, Japan, Australia, South Korea will be the lucrative markets for proteomics products.
What are the key end users of proteomics products & services?
The end users for proteomics products are Hospitals; Clinical Laboratories; Pharmaceutical Companies; and Academic Research Laboratories. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 32)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.1 MARKETS COVERED
FIGURE 2 PROTEOMICS MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
FIGURE 6 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION
2.2.2 TOP-DOWN APPROACH
FIGURE 7 PROTEOMICS MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 9 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 10 PROTEOMICS MARKET, BY REAGENT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 PROTEOMICS MARKET, BY SERVICE & SOFTWARE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 PROTEOMICS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PROTEOMICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PROTEOMICS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 49)
4.1 PROTEOMICS MARKET OVERVIEW
FIGURE 15 INCREASING DEMAND FOR PERSONALIZED MEDICINE TO DRIVE MARKET GROWTH
4.2 SPECTROSCOPY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 MASS SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 ELECTROPHORESIS MARKET SHARE, BY TYPE, 2021 VS. 2026
FIGURE 17 GEL ELECTROPHORESIS SEGMENT WILL ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
4.4 PROTEOMICS MARKET, BY REGION (2021−2026)
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing demand for personalized medicine
FIGURE 20 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 20082020
5.2.1.2 Rising prevalence of cancer and associated genetic disorders
TABLE 1 CANCER INCIDENCE AND MORTALITY, BY REGION, 20122035
5.2.1.3 Proteomics bridges the gap between genomics and biochemistry
5.2.1.4 Increasing pharmaceutical and biotechnology R&D expenditure
FIGURE 21 R&D EXPENDITURE BY PHRMA MEMBER COMPANIES, 20012019 (USD BILLION)
TABLE 2 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2018
TABLE 3 FUNDING FOR NIH INNOVATION PROJECTS UNDER THE 21ST CENTURY CURES ACT, 20172026
5.2.1.5 Technological advancements
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of instruments
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Growing prominence of nanoproteomics
5.2.3.2 Development of personalized proteomics for precision health
5.2.3.3 High growth opportunities in emerging countries
5.2.4 MARKET CHALLENGES
5.2.4.1 Data management in proteomics research
5.2.4.2 Low biomarker discovery-to-approval ratio
5.3 IMPACT OF COVID-19 ON THE PROTEOMICS MARKET
5.4 PATENT ANALYSIS
FIGURE 22 PROTEOMICS MARKET: PATENT ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 23 PROTEOMICS MARKET: VALUE CHAIN ANALYSIS
5.6.1 VALUE CHAIN ANALYSIS, BY ORGANIZATION
5.6.2 VALUE CHAIN ANALYSIS, BY MAJOR SPECIALIZATION
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 24 PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS
5.8 PORTERS FIVE FORCES ANALYSIS
FIGURE 25 PROTEOMICS MARKET: PORTERS FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PESTEL ANALYSIS
FIGURE 26 PROTEOMICS MARKET: PESTEL ANALYSIS
5.10 TRADE ANALYSIS
5.10.1 TRADE ANALYSIS FOR ELECTROPHORESIS & CHROMATOGRAPHY INSTRUMENTS
TABLE 4 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2016-2020 (USD MILLION)
5.10.2 TRADE ANALYSIS FOR SPECTROSCOPY INSTRUMENTS
TABLE 5 IMPORT DATA FOR SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2016-2020 (USD MILLION)
5.11 REGULATORY GUIDELINES
5.11.1 NORTH AMERICA
5.11.2 EUROPE
5.11.3 EMERGING MARKETS
6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY (Page No. - 72)
6.1 INTRODUCTION
6.1.1 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICES OF PRODUCTS AND SERVICES, 2021 (USD)
TABLE 7 PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 8 PROTEOMICS INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 9 PROTEOMICS INSTRUMENTATION TECHNOLOGY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.2 SPECTROSCOPY
TABLE 10 SPECTROSCOPY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 11 SPECTROSCOPY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.2.1 MASS SPECTROSCOPY
6.2.1.1 The ability of MS to identify small amounts of protein from increasingly complex mixtures is a major factor driving its use in proteomics
TABLE 12 MASS SPECTROSCOPY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.2.2 NMR SPECTROSCOPY
6.2.2.1 NMR experiments are used to evaluate the physical, chemical, electronic, and structural information of proteins
TABLE 13 NMR SPECTROSCOPY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.2.3 CD SPECTROSCOPY
6.2.3.1 CD spectroscopy is used to examine changes in secondary structures of proteins in response to environmental conditions
TABLE 14 CD SPECTROSCOPY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.3 CHROMATOGRAPHY
TABLE 15 CHROMATOGRAPHY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 16 CHROMATOGRAPHY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.3.1 HPLC
6.3.1.1 The two types of HPLC systems commonly available in the market are split-flow systems and non-split-flow systems
TABLE 17 HPLC MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.3.2 ION CHROMATOGRAPHY
6.3.2.1 Ion chromatography is the most commonly used chromatographic method for separating proteins
TABLE 18 ION CHROMATOGRAPHY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.3.3 AFFINITY CHROMATOGRAPHY
6.3.3.1 Affinity chromatography is used for the isolation of proteins based on the interaction between target proteins and specific immobilized ligands
TABLE 19 AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
6.3.4.1 SFC is used for the separation and analysis of integral membrane proteins and hydrophobic peptides
TABLE 20 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.4 ELECTROPHORESIS
TABLE 21 ELECTROPHORESIS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 22 ELECTROPHORESIS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.4.1 GEL ELECTROPHORESIS
6.4.1.1 The most common use of gel electrophoresis is the qualitative analysis of a complex mixture of proteins
TABLE 23 GEL ELECTROPHORESIS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.4.2 CAPILLARY ELECTROPHORESIS
6.4.2.1 CE coupled with MS is used to assess the structure and identity of individual proteins
TABLE 24 CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5 PROTEIN MICROARRAYS
TABLE 25 PROTEIN MICROARRAYS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 26 PROTEIN MICROARRAYS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.1 BIOCHIPS
TABLE 27 BIOCHIPS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 28 BIOCHIPS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.1.1 Lab-on-chips
6.5.1.1.1 LOC is one of the fastest-growing areas of microfabrication and nanotechnology development
TABLE 29 LAB-ON-CHIPS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.1.2 Protein chips
6.5.1.2.1 Protein chips are used to study protein interactions
TABLE 30 PROTEIN CHIPS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.2 MICROARRAY INSTRUMENTS
TABLE 31 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 32 MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.2.1 Integrated systems
6.5.2.1.1 Integrated systems can carry out the entire procedure of protein analysis without any intermediate steps
TABLE 33 INTEGRATED SYSTEMS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.2.2 Microarray scanners
6.5.2.2.1 Microarray scanners find applications in the data analysis of proteins, tissues, and cells
TABLE 34 MICROARRAY SCANNERS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.5.2.3 Arrayers
6.5.2.3.1 Technological advancements have made microarray spotters ideal for large-scale arraying projects
TABLE 35 ARRAYERS MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.6 X-RAY CRYSTALLOGRAPHY
6.6.1 X-RAY CRYSTALLOGRAPHY HELPS IN THE MEASUREMENT OF THE 3D DENSITY DISTRIBUTION OF ELECTRONS IN A CRYSTALLIZED PROTEIN
TABLE 36 X-RAY CRYSTALLOGRAPHY MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.7 SURFACE PLASMON RESONANCE
6.7.1 SPR IMAGING HELPS MONITOR A RANGE OF MOLECULAR INTERACTIONS
TABLE 37 SURFACE PLASMON RESONANCE MARKET, BY COUNTRY, 20192026 (USD MILLION)
6.8 PROTEIN FRACTIONATION
6.8.1 PROTEIN FRACTIONATION ENABLES THE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN A COMPLEX MIXTURE
TABLE 38 PROTEIN FRACTIONATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
7 PROTEOMICS MARKET, BY REAGENT (Page No. - 106)
7.1 INTRODUCTION
TABLE 39 PROTEOMICS REAGENTS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 40 PROTEOMICS REAGENTS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2 IMMUNOASSAY REAGENTS
7.2.1 IMMUNOASSAY REAGENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 41 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.3 SPECTROSCOPY REAGENTS
7.3.1 THE USE OF THESE REAGENTS IS INCREASING WITH THE RISING ADOPTION OF MS TECHNIQUES
TABLE 42 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.4 CHROMATOGRAPHY REAGENTS
7.4.1 INCREASING DEMAND FOR PROTEIN PURIFICATION IS EXPECTED TO DRIVE MARKET GROWTH
TABLE 43 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.5 PROTEIN MICROARRAY REAGENTS
7.5.1 THE USE OF THESE REAGENTS HAS INCREASED FOR ANALYZING PROTEIN INTERACTIONS
TABLE 44 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
7.6.1 X-RAY CRYSTALLOGRAPHY PLAYS AN IMPORTANT ROLE IN PROTEIN STRUCTURE DETERMINATION
TABLE 45 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.7 ELECTROPHORESIS REAGENTS
7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS IS DRIVING THE ADOPTION OF THESE REAGENTS
TABLE 46 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
7.8 PROTEIN FRACTIONATION REAGENTS
7.8.1 INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES IS DRIVING THE GROWTH OF THIS SEGMENT
TABLE 47 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 20192026 (USD MILLION)
8 PROTEOMICS MARKET, BY SERVICE & SOFTWARE (Page No. - 116)
8.1 INTRODUCTION
TABLE 48 PROTEOMICS SERVICES & SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 49 PROTEOMICS SERVICES & SOFTWARE MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2 CORE PROTEOMICS SERVICES
TABLE 50 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 51 CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.1 PROTEIN IDENTIFICATION SERVICES
8.2.1.1 Protein identification services dominate the market
TABLE 52 PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.2 PROTEIN CHARACTERIZATION SERVICES
8.2.2.1 Characterization studies play a vital role in studying complex protein structure, drug development, and PTMs
TABLE 53 PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2019 - 2026 (USD MILLION)
8.2.3 QUANTITATIVE PROTEOMICS SERVICES
8.2.3.1 Quantitative proteomics is critical for understanding protein expression and modifications
TABLE 54 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.4 PROTEIN PURIFICATION SERVICES
8.2.4.1 Protein purification aids in improving the overall proteome analysis
TABLE 55 PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.5 PROTEIN SEPARATION SERVICES
8.2.5.1 Separation plays an important role in the characterization of large-sized proteomes
TABLE 56 PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.6 PROTEIN SEQUENCING SERVICES
8.2.6.1 Identification and characterization of PTMs is an important area of research that needs protein sequencing
TABLE 57 PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.2.7 CUSTOM ASSAY SERVICES
8.2.7.1 Custom assays are adopted to improve the validation or consistency of the protein analysis procedures
TABLE 58 CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.3 BIOINFORMATICS SOFTWARE & SERVICES
TABLE 59 BIOINFORMATICS SOFTWARE & SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 60 BIOINFORMATICS SOFTWARE & SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.3.1 BIOINFORMATICS SERVICES
8.3.1.1 Bioinformatics services will dominate the market in the forecast period
TABLE 61 BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.3.2 BIOINFORMATICS TOOLS
8.3.2.1 Need for data management makes bioinformatics tools an imperative part of proteomics
TABLE 62 BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 20192026 (USD MILLION)
8.3.3 BIOINFORMATICS DATABASES
8.3.3.1 Databases majorly contribute to storing proteomics data along with integrating other omics databases
TABLE 63 BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 20192026 (USD MILLION)
9 PROTEOMICS MARKET, BY APPLICATION (Page No. - 136)
9.1 INTRODUCTION
TABLE 64 PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
9.2 CLINICAL DIAGNOSTICS
TABLE 65 MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 66 MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 20192026 (USD MILLION)
9.2.1 CANCER
9.2.1.1 Increasing number of research studies in cancer therapeutics to drive the market growth
TABLE 67 CLINICAL DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 20192026 (USD MILLION)
9.2.2 INFECTIOUS DISEASES
9.2.2.1 Increasing prevalence of infectious diseases to drive the market growth
TABLE 68 CLINICAL DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 20192026 (USD MILLION)
9.2.3 DIABETES
9.2.3.1 High burden of diabetes to propel market growth
TABLE 69 CLINICAL DIAGNOSTICS MARKET FOR DIABETES, BY COUNTRY, 20192026 (USD MILLION)
9.2.4 NEUROLOGICAL DISORDERS
9.2.4.1 Rising prevalence of neurological disorders to support market growth
TABLE 70 CLINICAL DIAGNOSTICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 20192026 (USD MILLION)
9.2.5 AUTOIMMUNE DISEASES
9.2.5.1 Increasing prevalence of autoimmune diseases to drive the market growth
TABLE 71 CLINICAL DIAGNOSTICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 20192026 (USD MILLION)
9.2.6 CARDIOVASCULAR DISEASES
9.2.6.1 High burden of CVD has increased the focus on developing reliable diagnostic tools
TABLE 72 CLINICAL DIAGNOSTICS MARKET FOR CVD, BY COUNTRY, 20192026 (USD MILLION)
9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
TABLE 73 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 20192026 (USD MILLION)
9.3 DRUG DISCOVERY
TABLE 74 MARKET FOR DRUG DISCOVERY, BY TYPE, 20192026 (USD MILLION)
TABLE 75 MARKET FOR DRUG DISCOVERY, BY COUNTRY, 20192026 (USD MILLION)
9.3.1 TARGET DISCOVERY
9.3.1.1 Increasing demand for personalized medicine to support the growth of this market
TABLE 76 DRUG DISCOVERY MARKET FOR TARGET DISCOVERY, BY COUNTRY, 20192026 (USD MILLION)
9.3.2 LEAD IDENTIFICATION
9.3.2.1 Lead identification is the most revenue-generating process
TABLE 77 DRUG DISCOVERY MARKET FOR LEAD IDENTIFICATION, BY COUNTRY, 20192026 (USD MILLION)
9.3.3 LEAD OPTIMIZATION
9.3.3.1 Lead optimization requires state-of-the-art informatics systems to facilitate transparent presentation and analysis
TABLE 78 DRUG DISCOVERY MARKET FOR LEAD OPTIMIZATION, BY COUNTRY, 20192026 (USD MILLION)
9.3.4 PRECLINICAL STUDIES
9.3.4.1 FDA requires researchers to use GLP during preclinical studies
TABLE 79 DRUG DISCOVERY MARKET FOR PRECLINICAL STUDIES, BY COUNTRY, 20192026 (USD MILLION)
9.4 OTHER APPLICATIONS
TABLE 80 DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
10 PROTEOMICS MARKET, BY END USER (Page No. - 154)
10.1 INTRODUCTION
TABLE 81 PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
10.2 PHARMACEUTICAL COMPANIES
10.2.1 RISING FOCUS ON DRUG DISCOVERY TO DRIVE MARKET GROWTH
TABLE 82 PROTEOMICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 20192026 (USD MILLION)
10.3 ACADEMIC RESEARCH LABORATORIES
10.3.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
TABLE 83 PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 20192026 (USD MILLION)
10.4 HOSPITALS
10.4.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET GROWTH
TABLE 84 PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 20192026 (USD MILLION)
10.5 CLINICAL LABORATORIES
10.5.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS IS SUPPORTING THE GROWTH OF THIS END-USER SEGMENT
TABLE 85 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 20192026 (USD MILLION)
10.6 OTHER END USERS
TABLE 86 PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 20192026 (USD MILLION)
11 PROTEOMICS MARKET, BY REGION (Page No. - 163)
11.1 INTRODUCTION
TABLE 87 PROTEOMICS MARKET, BY REGION, 20192026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET, BY END USER, 20192026 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the North American proteomics market
TABLE 92 US: MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 93 US: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 94 US: MARKET, BY END USER, 20192026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Strong infrastructure and availability of funding for biomedical research will support market growth
TABLE 95 CANADA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 96 CANADA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 97 CANADA: MARKET, BY END USER, 20192026 (USD MILLION)
11.3 EUROPE
TABLE 98 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 99 EUROPE: MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 100 EUROPE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 101 EUROPE: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany is the largest market for proteomics in Europe
TABLE 102 GERMANY: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 103 GERMANY: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 104 GERMANY: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.2 UK
11.3.2.1 The UK has seen a surge in the prevalence of cancer
TABLE 105 UK: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 106 UK: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 107 UK: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Proteomics research in France is strongly supported by the government
TABLE 108 FRANCE: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 109 FRANCE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 110 FRANCE: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.4 SWITZERLAND
11.3.4.1 Market growth is primarily driven by the well-established pharmaceutical & biotechnology industry in the country
TABLE 111 SWITZERLAND: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 112 SWITZERLAND: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 113 SWITZERLAND: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Growth in this market is mainly driven by increasing life science R&D
TABLE 114 ITALY: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 115 ITALY: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 116 ITALY: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Spain has a well-established network of research centers, universities, and hospitals
TABLE 117 SPAIN: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 118 SPAIN: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 119 SPAIN: MARKET, BY END USER, 20192026 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 120 ROE: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 121 ROE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 122 ROE: MARKET, BY END USER, 20192026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
TABLE 123 APAC: MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 124 APAC: MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 125 APAC: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 126 APAC: MARKET, BY END USER, 20192026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 China is the fastest-growing market for proteomics
TABLE 127 CHINA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 128 CHINA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 129 CHINA: MARKET, BY END USER, 20192026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Large number of research initiatives towards the development of precision medicine is driving market growth
TABLE 130 JAPAN: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 131 JAPAN: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 132 JAPAN: MARKET, BY END USER, 20192026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Large number of proteomics and genomics research studies undertaken in the country to support market growth
TABLE 133 INDIA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 134 INDIA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 135 INDIA: MARKET, BY END USER, 20192026 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
TABLE 136 AUSTRALIA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 137 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 138 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 139 ROAPAC: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 140 ROAPAC: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 141 ROAPAC: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.5 LATIN AMERICA
TABLE 142 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 143 LATIN AMERICA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 144 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 145 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Growing contract research and manufacturing activities in the country to support market growth
TABLE 146 BRAZIL: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 147 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 148 BRAZIL: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Strong pharmaceutical industry in the country to provide significant growth opportunities
TABLE 149 MEXICO: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 150 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 151 MEXICO: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 152 ROLATAM: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 153 ROLATAM: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 154 ROLATAM: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT MARKET GROWTH
TABLE 155 MEA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 156 MEA: PROTEOMICS MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 157 MEA: PROTEOMICS MARKET, BY END USER, 20192026 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 204)
12.1 OVERVIEW
FIGURE 29 KEY DEVELOPMENTS IN THE PROTEOMICS MARKET, JANUARY 2018JANUARY 2021
12.2 MARKET SHARE ANALYSIS
FIGURE 30 PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2019
12.3 COMPANY EVALUATION QUADRANT
12.3.1 DEFINITION AND METHODOLOGY
12.3.2 VENDOR DIVE OVERVIEW
12.3.2.1 Stars
12.3.2.2 Emerging leaders
12.3.2.3 Pervasive players
12.3.2.4 Participants
FIGURE 31 PROTEOMICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
12.4 COMPANY EVALUATION MATRIX FOR STARTUPS (2019)
12.4.1 PROGRESSIVE COMPANIES
12.4.2 RESPONSIVE COMPANIES
12.4.3 STARTING BLOCKS
12.4.4 DYNAMIC COMPANIES
FIGURE 32 PROTEOMICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS, 2019
12.5 COMPETITIVE SCENARIO
FIGURE 33 MARKET EVALUATION FRAMEWORK, JANUARY 2018 JANUARY 2021
12.5.1 PRODUCT LAUNCHES
TABLE 158 PRODUCT LAUNCHES, JANUARY 2018JANUARY 2021
12.5.2 EXPANSIONS
TABLE 159 EXPANSIONS, JANUARY 2018JANUARY 2021
12.5.3 ACQUISITIONS
TABLE 160 ACQUISITIONS, JANUARY 2018JANUARY 2021
12.5.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
TABLE 161 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2018JANUARY 2021
13 COMPANY PROFILES (Page No. - 213)
(Business overview, Products offered, Recent developments, MNM view)*
13.1 KEY PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC, INC.
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
13.1.2 AGILENT TECHNOLOGIES, INC.
FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
13.1.3 MERCK KGAA
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019)
13.1.4 DANAHER CORPORATION
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
13.1.5 WATERS CORPORATION
FIGURE 38 WATERS CORPORATION: COMPANY SNAPSHOT (2019)
13.1.6 BIO-RAD LABORATORIES, INC.
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
13.1.7 BRUKER CORPORATION
FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
13.1.8 GE HEALTHCARE
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
13.1.9 PERKINELMER, INC.
FIGURE 42 PERKINELMER: COMPANY SNAPSHOT (2019)
13.1.10 LUMINEX CORPORATION
FIGURE 43 LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)
13.1.11 EUROFINS SCIENTIFIC
FIGURE 44 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
13.1.12 HORIBA, LTD.
FIGURE 45 HORIBA, LTD.: COMPANY SNAPSHOT (2019)
13.1.13 ILLUMINA, INC.
FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
13.1.14 QIAGEN N.V.
FIGURE 47 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
13.2 OTHER PLAYERS
13.2.1 CREATIVE PROTEOMICS
13.2.2 PROMEGA CORPORATION
13.2.3 SENGENICS
13.2.4 BIOMAX INFORMATICS AG
13.2.5 MS BIOWORKS, LLC
13.2.6 WUXI NEXTCODE
13.2.7 FIOS GENOMICS, LTD.
13.2.8 GENEWIZ
13.2.9 BIOGNOSYS AG
13.2.10 BIOPROXIMITY
13.2.11 MRM PROTEOMICS INC.
13.2.12 INTEGRATED PROTEOMICS APPLICATIONS
13.2.13 POOCHON SCIENTIFIC LLC
13.2.14 PROTEOME FACTORY AG
13.2.15 VPROTEOMICS
13.2.16 APPLIED BIOMICS INC.
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 285)
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 ADDITIONAL INSIGHTS
14.2.1 MASS SPECTROMETRY
14.2.2 QUANTITATIVE PROTEOMICS
14.2.3 TARGETED PROTEOMICS
14.3 DISCUSSION GUIDE
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
14.5 AVAILABLE CUSTOMIZATIONS
14.6 RELATED REPORTS
14.7 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industrys value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information and assess future prospects.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the proteomics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the proteomics market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, service and software, application, end user, and region
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the proteomics market with respect to five main regions (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) along with their respective key countries
- To profile the key players in the global proteomics market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, partnerships, agreements, joint ventures, and R&D activities of the leading players in the proteomics market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for this report:
Country Information
- Proteomics market size and growth rate estimates for counties in Rest of Europe, the Rest of Asia Pacific and Rest of the World
Company profiles
- Additional five company profiles of players operating in the proteomics market
Growth opportunities and latent adjacency in Proteomics Market
Looking to gain more insights on the global Proteomics Market
What are the growth opportunities in Proteomics Market?
Can you enlighten us on geographical growth analysis in Proteomics Market?